Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Feb 2014

Ponzoni M, Issa S, Batchelor T T, Rubenstein J L

Abstract excerpt

BACKGROUND: While there has been significant progress in outcomes for patients diagnosed with primary central nervous system (CNS) lymphoma (PCNSL), survival rates will likely plateau with the current armamentarium of agents used to treat these patients. Moreover, given that PCNSL increasingly impacts an older population, a significant proportion of patients are not eligible for intensive therapies such as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Central Nervous System Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemoradiotherapy

Share to BCL6 gene

Share to Lymphoma

Share to Methotrexate

Share to Phenotype

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 24265352
DOI: 10.1093/annonc/mdt385
PMCID: PMC3905778

Genes

BCL6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma.PMID 24265352Read ↗

Primary Central Nervous System Lymphoma: Evolving Biologic Insights and Recent Therapeutic Advances.Semantic proximity Read ↗

Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities.Semantic proximity Read ↗

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in TreatmentSemantic proximity Read ↗

The genomic and transcriptional landscape of primary central nervous system lymphomaSemantic proximity Read ↗

Insights into the biology of primary central nervous system lymphoma.Semantic proximity Read ↗

Targetable genetic features of primary testicular and primary central nervous system lymphomasSemantic proximity Read ↗

Molecular and clinical diversity in primary central nervous system lymphoma.Semantic proximity Read ↗

Pathology and new insights in central nervous system lymphomas.Semantic proximity Read ↗

Mutational analysis of primary central nervous system lymphoma.Semantic proximity Read ↗

Unraveling MCL biology to understand resistance and identify vulnerabilitiesSemantic proximity Read ↗

Optimizing therapy for nodal marginal zone lymphomaSemantic proximity Read ↗

Emerging insights into origin and pathobiology of primary central nervous system lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.